3393. Пакет №152 (ПЛР. ВПЛ 6, 11 та ВПЛ ВКР 14 (сobas HPV схвалений FDA))
Number of tests: 2
PCR. HPV HCR 14 (cobas HPV FDA approved). Genotyping 16 and 18 and groups 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 (u/g scrape, qualitative)
PCR. HPV 6, 11 (qualitative determination)
Turnaround time (days): 3
1770 ₴
Important information
* TEST FOR WOMEN ONLY
Description
Package №152 – PCR for HPV 6,11 and screening test for 14 oncogenic HPV types. The package provides qualitative detection of HPV types 6 and 11 (low oncogenic risk) and screening testing for 14 high-risk carcinogenic HPV types.
The testing is performed using real-time PCR on the Cobas system (FDA approved). The package complies with the requirements of the Ministry of Health of Ukraine Order No. 1057 regarding primary and repeat screening.
When and who needs the test?
- For primary screening in women aged 25 and older – once every 5 years (according to the Order of the Ministry of Health of Ukraine №1057).
- For women with an abnormal Pap test (ASC-US, LSIL, HSIL).
- In cases of suspected HPV-associated cervical changes.
- Co-testing (Pap + HPV test) is the recommended modern screening strategy.
- For the diagnosis of anogenital warts and mucosal papillomas.
Biological material
- Site-specific scrapings collected depending on the test
- Scrapes from various sites depending on the test
Preparation for cytology
- Collect the material before starting treatment with antibacterial/antifungal drugs (general and local action).
- In case of treatment monitoring – 14 days after the end of the course of treatment with antibacterial/antifungal drugs.
- Avoid sexual intercourse for 3 days.
- Exclude douching and the use of vaginal...